Gw-501516 Cardarine Sarms Steroids for Losing Weight
|FOB Price:||US $1-6 / grams|
|Min. Order:||10 grams|
|Min. Order||FOB Price|
|10 grams||US $1-6/ grams|
|Port:||Hong Kong, Hong Kong|
|Payment Terms:||T/T, Western Union, Paypal, Money Gram|
- Model NO.: 99
- Customized: Customized
- Suitable for: Adult
- Purity: >99%
- CAS No: 317318-70-0
- M.W: 453.50
- Appearance: White Fine Powder
- Transport Package: Very Discreet or as Required
- Origin: China
- Powder: Yes
- Certification: GMP, ISO 9001, USP, BP
- State: Solid
- Product Name: Gw-501516
- M.F: C21h20f3no3s2
- Assays: 99%
- Trademark: BETTLI
- Specification: GMP, SGS, ISO, KOSHER
- HS Code: 3001200020
Product name: GW501516 (cardarine)
Appearance: white solid
Usage: It had been investigated as a potential treatment for obesity, diabetes, dyslipidemia and cardiovascular disease. GW501516 could be used by athletes as an ergogenic performance enhancing drug.
GW-501516 is a unique medication officially classified as a PPAR receptor agonist (PPAR-RA). Research for this medication began in 1992 in a conjoined effort between GlaxoSmithKline (GSK) and Ligand Pharmaceuticals. Research into this product was set forth in an effort to provide treatment for various cardiovascular diseases, as well as diabetes, obesity and other conditions. It was soon discovered that the PPAR-RA was highly effective at enhancing endurance, but it was also shown to carry a high potential cost. It was discovered that GW-501516 increased the chances of cancer significantly, and as a result, GSK dropped all further research. However, the studies that produced cancerous results used doses of GW-501516 that were 500 to even 1000 times the amount that a human being would take. If cancer is a risk with standard dosing is unknown.
GW-501516 Functions and Traits
GW-501516 binds to the PPAR receptor, specifically a group of nuclear receptors (sensors that detect thyroid and steroidal hormones in the body) that initiates the PGC-1a enzyme. This action leads to gene expression, specifically genes that revolve around energy expenditure.
Studies involving GW-501516 have shown to increase the metabolism of fatty acids in rats. It was also shown in the same studies to reduce the odds of obesity despite poor eating habits as well as prevent Type-2 diabetes. GW-501516 was also shown to increase HDL (good cholesterol) and decrease LDL (bad cholesterol) in a study using monkeys. The effects seemed to hold true with or without exercise.
|Code||Product Name||CAS Number||Code||Product Name||CAS Number|